Study Title
Optimisation and Safety of an Innovative Nuclear Medicine Treatment: Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
Study Details
Description:
Single-centre, retrospective and prospective observational study. This study aims to evaluate the dose delivered by radiation to the tumour and organs at risk, as a factor predicting response and the appearance of toxicities. Dosimetric calculations are made for each treatment using scintigraphic images acquired following injection of 177Lu-PSMA-617.
Sponsor:
Institut Bergonié
Contacts:
Nadège ANIZANn.anizan@bordeaux.unicancer.fr
+33556333347
Government Study Link:
NCT06700057 - Click here to see study onClinicalTrials.gov
Drug Details
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468